Deutsche Bank Ag\ Compugen LTD Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.57 - $3.33 $15,874 - $33,669	-10,111 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.76 - $4.64 $6,927 - $11,646	2,510 Added 33.02%	10,111 $33,000
Q4 2021 Feb 11, 2022	SELL	$4.09 - $7.16 $1,766 - $3,093	-432 Reduced 5.38%	7,601 $33,000
Q3 2021 Nov 04, 2021	SELL	$5.8 - $8.02 $218,120 - $301,608	-37,607 Reduced 82.4%	8,033 $48,000
Q2 2021 Aug 11, 2021	BUY	$6.87 - $9.16 $88,980 - $118,640	12,952 Added 39.62%	45,640 $378,000
Q1 2021 May 13, 2021	BUY	$7.67 - $13.77 $198,507 - $356,381	25,881 Added 380.21%	32,688 $280,000
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $26,083 - $38,789	2,161 Added 46.51%	6,807 $82,000
Q3 2020 Nov 12, 2020	BUY	$14.16 - $19.45 $65,787 - $90,364	4,646 New	4,646 $75,000
Q1 2020 May 14, 2020	SELL	$5.79 - $11.83 $52,057 - $106,363	-8,991 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.9 - $6.16 $35,064 - $55,384	8,991 New	8,991 $53,000
Q1 2018 May 15, 2018	SELL	$2.5 - $4.45 $23,920 - $42,577	-9,568 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.35 - $4.0 $18,057 - $30,736	7,684 Added 407.86%	9,568 $23,000
Q3 2017 Nov 14, 2017	BUY	$2.75 - $3.95 $5,181 - $7,441	1,884	1,884 $6,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $138M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.